Importantly, SAA has been described as an innate regulator of granulomatous lung inflammation in sarcoidosis acting through Toll-like receptor-2 [34], as well as mediator of glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease (COPD) [35]. This evidence concerns the gene SAA1 and chronic obstructive pulmonary disease.